Stability of a standardized preparation of methotrexate, cytarabine, and methylprednisolone hemisuccinate for intrathecal use.

Gianluca PeregoGiorgia LongobardoLucia ViganòAlberta LocatelliCinzia VenezianoMaria Fazio

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

Triple intrathecal solution of methotrexate, cytarabine, and methylprednisolone hemisuccinate is stable for up to 24 h when stored in polypropylene syringes protected from light at 4°C and 20°C.

Keyphrases

high dose
low dose
room temperature
acute myeloid leukemia
molecularly imprinted